Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × GEN-1 × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Carboplatin 4 Paclitaxel 3 Bevacizumab 3 trastuzumab deruxtecan 1 rucaparib 1 pembrolizumab 1 olaparib 1 niraparib 1 mirvetuximab soravtansine 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Nivolumab 1 Hyperthermic Intraperitoneal Chemotherapy 1 Glucose 1 GEN-1 1 Drug Therapy 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06915025 2026-02-27

OVATION-3

Imunon

Phase 3 Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡